Why the study?
Is catheter ablation for atrial fibrillation safe and effective in elderly patients compared to younger patients?
Is catheter ablation for atrial fibrillation safe and effective in elderly patients compared to younger patients?
Catheter ablation for atrial fibrillation is equally safe and effective in elderly patients as in younger patients, though older patients are more likely to remain on antiarrhythmic drugs.
Answers are grounded in this paper and cite their sources.
Supports ablation consideration in selected elderly AF patients; extends observational data but leaves open randomized confirmation.
INTRODUCTION: The number of elderly patients with atrial fibrillation (AF) is increasing rapidly, and the safety and efficacy of catheter ablation in this demographic group has not been established. METHODS: Over a 7-year period we studied 1,165 consecutive patients undergoing 1,506 AF ablation procedures using a consistent ablation protocol that included proximal ostial pulmonary vein (PV) isolation and focal ablation of non-PV AF triggers. Outcome was analyzed for three distinct age groups: <65 years (group 1; n = 948 patients), 65-74 years (group 2; n = 185 patients), and > or =75 years (group 3; n = 32 patients) based on the age at the initial procedure. RESULTS: There was no significant difference in AF control (89% in group 1, 84% in group 2, and 86% in group 3, P = NS) during a mean follow-up of 27 months. Major complication rates were also comparable (1.6% in group 1, 1.7% in group 2, 2.9% in group 3, P = NS) between the three groups. There was no difference in the left atrial size, percentage with left ventricular ejection fraction <50%, or percentage with paroxysmal versus more persistent forms of atrial fibrillation. However, older patients were more likely to be women (20% in group 1, 34% in group 2, and 56% in group 3, P < 0.001) and have hypertension and/or structural heart disease (56% in group 1 vs 68% in group 2 vs 88% in group 3; P < 0.001). There was a strong trend demonstrating that older patients were less likely to undergo repeat ablation (26% vs 27% vs 9%) to achieve AF control and more likely to remain on antiarrhythmic drugs (20% vs 29% vs 37%; P < 0.05). CONCLUSIONS: Elderly patients with AF undergoing catheter ablation therapy are represented by a higher proportion of women and have a higher incidence of hypertension/structural heart disease. To achieve a similar level of AF control, there appears to be no increased risk from the ablation procedure, but elderly patients are more likely to remain on antiarrhythmic drugs.
No takes yet. Share an insight, caveat, or question.
Zado et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: